Search clinical trials for: regorafenib plus anti-PD-1 antibodies
Total 930 results
-
Beijing Tongren HospitalNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal Type
-
Fudan UniversityNot yet recruitingGastric Cancer | MSI-H | Adjuvant Therapy | PD-1 ImmunotherapyChina
-
Cancer Hospital of Guangxi Medical UniversityUnknownHepatocellular CarcinomaChina
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Shanghai Celfuture Biotech Co., Ltd.Not yet recruiting
-
Hunan Cancer HospitalCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Ningbo Cancer HospitalUnknownAdvanced Cancer | Solid Tumor, AdultChina
-
OncoC4, Inc.Avance Clinical; OncoC4 AU Pty LtdRecruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Fallopian Tube Cancer | Non Small Cell Lung Cancer | Bile Duct Cancer | Bladder Cancer | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Primary Peritoneal... and other conditionsAustralia
-
Sun Yat-sen UniversityShanghai Junshi Bioscience Co., Ltd.Active, not recruitingNasopharyngeal CarcinomaChina
-
Chinese PLA General HospitalRecruitingDiffuse Large B Cell Lymphoma | Central Nervous System Lymphoma | Extranodal Extension | Relapse/RecurrenceChina
-
Xiangya Hospital of Central South UniversityActive, not recruiting
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Henlix, IncUnknown
-
Second Affiliated Hospital, School of Medicine,...RecruitingRectal NeoplasmsChina
-
LiuYingNot yet recruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Henan Cancer HospitalCttqUnknown
-
Genentech, Inc.CompletedNeoplasmsUnited States, Spain, Belgium, Korea, Republic of, Canada, Australia, France
-
Fudan UniversityActive, not recruiting
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immune Checkpoint Inhibitors | Overall Survival | Anti-programmed Death-1 Antibody | Metastatic Cervical Carcinoma | Persistent Advanced Cervical Carcinoma | Objective Remission Rate | Progression-free Survival | Severe Adverse EventsChina
-
Agenus Inc.Withdrawn
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Beijing Friendship HospitalNot yet recruitingLymphoma | Hemophagocytic Lymphohistiocytosis | PD-1 Antibody | Epstein-Barr VirusChina
-
Beijing Friendship HospitalNot yet recruitingHemophagocytic LymphohistiocytosisChina
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalWithdrawn
-
Shanghai Cell Therapy Research InstituteUnknownAdvanced Solid TumorChina
-
Lee's Pharmaceutical LimitedNot yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedExtranodal NK/T Cell Lymphoma, Nasal TypeChina
-
Zhujiang HospitalNot yet recruitingHepatocellular Carcinoma Non-resectable
-
Wuhan Union Hospital, ChinaRecruitingColorectal AdenocarcinomaChina
-
TriSalus Life Sciences, Inc.RecruitingLocally Advanced Pancreatic AdenocarcinomaUnited States
-
Shanghai Chest HospitalRecruitingNon Small Cell Lung CancerChina
-
Coherus Biosciences, Inc.Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.Active, not recruitingHepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid TumorUnited States
-
The Affiliated Hospital of Qingdao UniversityUnknownNSCLC Stage IV | PD-1 | ARID1AChina
-
Ruijin HospitalNot yet recruitingNK-T-Cell Lymphoma, ExtranodalChina
-
Shanghai Jiao Tong University Affiliated Sixth...RecruitingCervical Cancer | Radiotherapy | Neoadjuvant Chemotherapy | PD-1 AntibodyChina
-
Xijing HospitalRecruitingGastric Cancer | Chemotherapeutic Toxicity | Immune-related Adverse EventChina
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
PfizerWithdrawnBladder CancerPoland, United States
-
Bio-Thera SolutionsTerminatedAdvanced Solid TumorAustralia
-
Jinling Hospital, ChinaRecruitingRenal Cell Carcinoma | Radiotherapy | Immune Checkpoint InhibitorChina
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingColorectal Cancer | Multiple CancerChina
-
Dragonboat Biopharmaceutical Company LimitedFudan UniversityRecruitingBladder Cancer | Renal Carcinoma | Advanced Penile CarcinomaChina
-
CytoDyn, Inc.Amarex Clinical ResearchWithdrawnColorectal Cancer | Microsatellite Stable | Metastatic | CCR5
-
Bio-Thera SolutionsTerminatedAdvanced Solid TumourAustralia
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingUterine Cervical CancerChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingExtensive Stage Small Cell Lung Cancer
-
Hangzhou Cancer HospitalAnhui Kedgene Biotechnology Co.,LtdCompleted
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Guangdong Provincial...Active, not recruitingColorectal Cancer | Microsatellite Instability HighChina
-
Chinese PLA General HospitalUnknown